BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis

[1]  E. S. St. Clair,et al.  B Cell Depletion Delays Collagen-Induced Arthritis in Mice: Arthritis Induction Requires Synergy between Humoral and Cell-Mediated Immunity1 , 2007, The Journal of Immunology.

[2]  Kutty Selva Nandakumar,et al.  Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis , 2007, Arthritis research & therapy.

[3]  C. Serhan,et al.  Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression , 2006, Nature Immunology.

[4]  G. Kingsley,et al.  Tumor necrosis factor inhibitors for rheumatoid arthritis. , 2006, The New England journal of medicine.

[5]  G. Firestein.  Inhibiting inflammation in rheumatoid arthritis. , 2006, The New England journal of medicine.

[6]  L. Dong,et al.  Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. , 2006, Kidney international.

[7]  P. Tsao,et al.  THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis , 2005, Arthritis research & therapy.

[8]  A. Silman,et al.  Genetic epidemiology of rheumatoid arthritis. , 2006, Current opinion in rheumatology.

[9]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[10]  E. Massarotti,et al.  Rheumatoid Arthritis: An Overview of New and Emerging Therapies , 2005, Journal of clinical pharmacology.

[11]  G. Firestein.  Immunologic Mechanisms in the Pathogenesis of Rheumatoid Arthritis , 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[12]  A. Sher,et al.  Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. , 2005, The Journal of clinical investigation.

[13]  A. Drosos,et al.  Epidemiology of adult rheumatoid arthritis. , 2005, Autoimmunity reviews.

[14]  J. Parkinson,et al.  A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Olsen,et al.  New drugs for rheumatoid arthritis. , 2004, The New England journal of medicine.

[16]  J. Varga,et al.  Opposing Regulation of Interleukin-8 and NF-kB Responses by Lipoxin A4 and Serum Amyloid a via the Common Lipoxin a Receptor , 2004, International journal of immunopathology and pharmacology.

[17]  Adriano G. Rossi,et al.  Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.

[18]  H. Offner,et al.  A synthetic androstene analogue inhibits collagen-induced arthritis in the mouse. , 2004, Clinical immunology.

[19]  A. Spagnolo,et al.  Lipoxin A4 Counteracts Synergistic Activation of Human Fibroblast-like Synoviocytes , 2004, International journal of immunopathology and pharmacology.

[20]  A. Kang,et al.  Immunopathogenesis of Collagen Arthritis , 2003, Springer Seminars in Immunopathology.

[21]  C. Serhan,et al.  Aspirin-Triggered Lipoxin A4 and B4 Analogs Block Extracellular Signal-Regulated Kinase-Dependent TNF-α Secretion from Human T Cells 1 , 2003, The Journal of Immunology.

[22]  J. Smolen,et al.  Therapeutic strategies for rheumatoid arthritis , 2003, Nature Reviews Drug Discovery.

[23]  T. Kagari,et al.  Essential Role of Fcγ Receptors in Anti-Type II Collagen Antibody-Induced Arthritis , 2003, The Journal of Immunology.

[24]  T. Kagari,et al.  Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis. , 2003, Journal of immunology.

[25]  K. Asadullah,et al.  An Aspirin-Triggered Lipoxin A4 Stable Analog Displays a Unique Topical Anti-Inflammatory Profile , 2002, The Journal of Immunology.

[26]  R. Price,et al.  Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. , 2002, Arthritis and rheumatism.

[27]  A. Tarkowski,et al.  Complement Deficiency Ameliorates Collagen-Induced Arthritis in Mice1 , 2002, The Journal of Immunology.

[28]  H. Rabb,et al.  15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. , 2002, Journal of the American Society of Nephrology : JASN.

[29]  J. Smith,et al.  Rheumatoid arthritis--a molecular understanding. , 2002, Annals of internal medicine.

[30]  A. Sher,et al.  Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity , 2002, Nature Immunology.

[31]  N. Williams,et al.  The genetic and immunopathological processes underlying collagen‐induced arthritis , 2001, Immunology.

[32]  G. Panayi,et al.  Cytokine pathways and joint inflammation in rheumatoid arthritis. , 2001, The New England journal of medicine.

[33]  Edward F. Rosloniec,et al.  Collagen‐Induced Arthritis , 1996, Current protocols in immunology.

[34]  J. Varga,et al.  Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of Metalloproteinases1 , 2000, The Journal of Immunology.

[35]  M. Rowley,et al.  Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[36]  S. Gupta,et al.  Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Y. Koide,et al.  Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. , 1998, Journal of immunology.

[38]  M. A. Cremer,et al.  The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease , 1998, Journal of Molecular Medicine.

[39]  M. Feldmann,et al.  Rheumatoid Arthritis , 1996, Cell.

[40]  B. Spur,et al.  Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships. , 1991, Biochemical and biophysical research communications.

[41]  S. Kerwar,et al.  Type II collagen-induced arthritis in rats. , 1988, Methods in enzymology.

[42]  A. Kang,et al.  Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis , 1982, The Journal of experimental medicine.